These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2321076)
1. Antiarrhythmic properties of amitriptyline. Colenda CC South Med J; 1990 Apr; 83(4):478-80. PubMed ID: 2321076 [TBL] [Abstract][Full Text] [Related]
3. Amitriptyline in the management of progressive supranuclear palsy. Kvale JN Arch Neurol; 1982 Jun; 39(6):387-8. PubMed ID: 7092626 [No Abstract] [Full Text] [Related]
4. Influence of imipramine and amitriptyline on the hypothalamic function in affective disorders. Horodnicki JM; Szakowski A; Wdowiak J Act Nerv Super (Praha); 1989 Apr; 31(1):27-9. PubMed ID: 2781995 [No Abstract] [Full Text] [Related]
5. Treatment of mood disorder associated with Binswanger's disease. Joyce EM; Levy R Br J Psychiatry; 1989 Feb; 154():259-61. PubMed ID: 2775957 [TBL] [Abstract][Full Text] [Related]
6. A class III antiarrhythmic agent. Pelter MM; Adams MG Am J Crit Care; 2002 Jul; 11(4):395-6. PubMed ID: 12102441 [No Abstract] [Full Text] [Related]
7. Cardiac and antiarrhythmic effects of imipramine in patients with ventricular arrhythmias. Giardina EG Biomed Pharmacother; 1984; 38(3):128-30. PubMed ID: 6478051 [TBL] [Abstract][Full Text] [Related]
8. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. Mason JW N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150 [TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia. Nademanee K; Hendrickson J; Kannan R; Singh BN Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035 [No Abstract] [Full Text] [Related]
10. The case for inpatient initiation of antiarrhythmic therapy. Myerburg RJ; Kloosterman M; Yamamura K; Mitrani R; Interian A; Castellanos A J Cardiovasc Electrophysiol; 1999 Mar; 10(3):482-7. PubMed ID: 10210516 [No Abstract] [Full Text] [Related]
11. Indications for antiarrhythmic therapy: a wealth of controversy, a dearth of data. Woosley RL Ann Intern Med; 1988 Mar; 108(3):450-2. PubMed ID: 3277517 [No Abstract] [Full Text] [Related]
12. When is QT prolongation antiarrhythmic and when is it proarrhythmic? Singh BN Am J Cardiol; 1989 Apr; 63(12):867-9. PubMed ID: 2929445 [No Abstract] [Full Text] [Related]
13. Mechanisms of arrhythmias: enhanced automaticity and reentry. Weller DM; Noone J Crit Care Nurse; 1989 May; 9(5):42-67. PubMed ID: 2680278 [TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic therapy. The value of the history of the patient. Wellens HJ; Brugada P Eur Heart J; 1987 Mar; 8 Suppl A():71-5. PubMed ID: 3582393 [TBL] [Abstract][Full Text] [Related]